{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T23:21:52Z","timestamp":1720221712097},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.vaccine.2007.04.047","type":"journal-article","created":{"date-parts":[[2007,5,8]],"date-time":"2007-05-08T13:33:55Z","timestamp":1178631235000},"page":"A83-A91","source":"Crossref","is-referenced-by-count":8,"special_numbering":"S1","title":["An evaluation of the immunogenicity and safety of a new trivalent meningococcal polysaccharide vaccine"],"prefix":"10.1016","volume":"25","author":[{"given":"Daniel","family":"Chandramohan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Hodgson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Baiden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwaku","family":"Asante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Awine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth","family":"Owusu-Agyei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Boutriau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher B.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brain","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.04.047_bib1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0035-9203(99)90106-2","article-title":"Meningococcal meningitis in Africa","volume":"93","author":"Greenwood","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2007.04.047_bib2","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(82)91533-1","article-title":"Emergence of meningococcal meningitis caused by W135 serogroup in Africa","volume":"2","author":"Denis","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.04.047_bib3","first-page":"141","article-title":"Meningococcal disease, serogroup W135","volume":"76","author":"Anonymous","year":"2001","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2007.04.047_bib4","first-page":"281","article-title":"Epidemics of meningococcal disease, African meningitis belt","volume":"76","author":"Anonymous","year":"2001","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2007.04.047_bib5","first-page":"141","article-title":"Meningococcal disease, serogroup W135, Bukina Faso","volume":"77","author":"Anonymous","year":"2002","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2007.04.047_bib6","doi-asserted-by":"crossref","unstructured":"Koumar\u00e9 B, Ouedraogo-Traor\u00e9 I, Sanou I, Yada A, Sow I, Lusamba P, et al. The first large epidemic of meningococcal disease caused by serogroup W135, Burkina Faso, 2002. Vaccine 2007 (this supplement).","DOI":"10.1016\/j.vaccine.2007.04.038"},{"key":"10.1016\/j.vaccine.2007.04.047_bib7","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.129.6.1367","article-title":"Human immunity to the meningococcus. IV. Immunogenicity of Group A and Group C meningococcal polysaccharides in human volunteers","volume":"129","author":"Gotschlich","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2007.04.047_bib8","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0140-6736(80)91230-1","article-title":"Control of meningococcal infection in the African meningitis belt by selective vaccination","volume":"i","author":"Greenwood","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.04.047_bib9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0140-6736(81)90423-2","article-title":"Control of epidemic meningitis by mass vaccination","volume":"i","author":"Mohammed","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.04.047_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0140-6736(82)90282-3","article-title":"Epidemic of meningococcal meningitis in Bamako, Mali; epidemiological features and analysis of vaccine efficacy","volume":"ii","author":"Binkin","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.04.047_bib11","first-page":"317","article-title":"Immunogenicity and side effects of a new tetravalent meningococcal polysaccharide vaccine","volume":"61","author":"Ambrosch","year":"1983","journal-title":"Bull WHO"},{"key":"10.1016\/j.vaccine.2007.04.047_bib12","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1128\/IAI.42.2.599-604.1983","article-title":"Reactivity and immunogenicity of bivalent (AC) and tetravalent (A\/C\/W135Y) meningococcal vaccines containing O-acetyl-negative or O-acetyl-positive C polysaccharide","volume":"42","author":"Vodopija","year":"1983","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.04.047_bib13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0264-410X(85)90266-X","article-title":"(A,C,Y, W135) meningococcal vaccine in children: immunogenicity and safety","volume":"3","author":"Cadoz","year":"1985","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.04.047_bib14","doi-asserted-by":"crossref","unstructured":"Soriano-Gabarro M, Toe L, Tiendrebeogo SRM, Nelson CB, Dabal M, Djingarey M, et al. Effectiveness of a trivalent serogroup A\/C\/W-135 meningococcal polysaccharide vaccine in Burkina Faso, 2003. Vaccine 2007 (this supplement).","DOI":"10.1016\/j.vaccine.2007.04.048"},{"key":"10.1016\/j.vaccine.2007.04.047_bib15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardisation and multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2007.04.047_bib16","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/JCM.32.6.1475-1482.1994","article-title":"Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay","volume":"32","author":"Gheesling","year":"1994","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2007.04.047_bib17","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/IAI.69.3.1568-1573.2001","article-title":"Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection","volume":"69","author":"Borrow","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.04.047_bib18","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England","volume":"10","author":"Andrews","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2007.04.047_bib19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/infdis\/137.2.112","article-title":"Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children","volume":"137","author":"Gold","year":"1978","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.04.047_bib20","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1086\/339010","article-title":"Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana","volume":"185","author":"Gagneux","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.04.047_bib21","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1128\/IAI.66.6.2453-2459.1998","article-title":"Age-dependant Neisseria meningitidis serogroup C class-specific antibody concentrations and bactericidal titres in sera from young children from Montana immunized with a licensed polysaccharide vaccine","volume":"66","author":"Maslanka","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.04.047_bib22","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/infdis\/142.6.861","article-title":"Serum antibodies to capsular polysaccharide vaccine group A Neisseria meningitidis followed for three years in infants and children","volume":"142","author":"Kayhty","year":"1980","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.04.047_bib23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1542\/peds.76.1.91","article-title":"Evaluation of two tetravalent (A\/C\/Y\/W135) meningococcal vaccines in infants and small children: a clinical study comparing immunogenicity of O-acetyl-negative and O-acetyl-positive group C polysaccharides","volume":"67","author":"Peltola","year":"1985","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2007.04.047_bib24","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1128\/IAI.73.5.2932-2939.2005","article-title":"Serologic response to ACYW135 polysaccharide meningococcal vaccine in Saudi children aged under 5 years","volume":"73","author":"AlMazrou","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.04.047_bib25","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/infdis\/154.6.1033","article-title":"Reactogenicity and immunogenicity of a quadrivalent combined meningococcal polysaccharide vaccine in children","volume":"154","author":"Lepow","year":"1986","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.04.047_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1128\/CDLI.11.1.83-88.2004","article-title":"Immunologic hyporesponsiveness to serogroup C but not serogroup A following repeated meningococcal A\/C polysaccharide vaccination in Saudi Arabia","volume":"11","author":"Jokhdar","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2007.04.047_bib27","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0264-410X(00)00317-0","article-title":"Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults","volume":"19","author":"Borrow","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.04.047_bib28","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/jama.280.19.1685","article-title":"Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers","volume":"280","author":"MacDonald","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2007.04.047_bib29","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1016\/S0264-410X(99)00139-5","article-title":"Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood","volume":"17","author":"MacLennan","year":"1999","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07004720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07004720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T19:02:35Z","timestamp":1683831755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07004720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":29,"alternative-id":["S0264410X07004720"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.04.047","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}